AR008838A1 - Nuevo tratamiento. - Google Patents
Nuevo tratamiento.Info
- Publication number
- AR008838A1 AR008838A1 ARP970104238A ARP970104238A AR008838A1 AR 008838 A1 AR008838 A1 AR 008838A1 AR P970104238 A ARP970104238 A AR P970104238A AR P970104238 A ARP970104238 A AR P970104238A AR 008838 A1 AR008838 A1 AR 008838A1
- Authority
- AR
- Argentina
- Prior art keywords
- pain
- neuralgia
- diseases
- treatment
- new treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Derivados y Análogos de benzopirano se describen como utiles para el tratamiento y/o la profilaxis de enfermedades degenerativas tales como corea deHuntingdon, esquizofrenia, déficit neurologicos asociados con el SIDA, trastornos delsueno (incluídos trastornos del ritmo circadiano, insomnio ynarcolepsia), tics (por ejemplo síndrome de Giles de la Tourette), lesion traumática del cerebro, zumbido, neuralgia, especialmente neuralgia trigémina,dolor neuropático, dolordental, dolor de cancer, actividad nuronal inapropiada que resulta en una neurodistesia en enfermedades tales como diabetes, EM, y laenfermedad de la neurona motora, ataxias, rigidez muscular (espasmos) y disfuncion de la uniontémporo-mandibular.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619492.3A GB9619492D0 (en) | 1996-09-18 | 1996-09-18 | Novel treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008838A1 true AR008838A1 (es) | 2000-02-23 |
Family
ID=10800127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970104238A AR008838A1 (es) | 1996-09-18 | 1997-09-16 | Nuevo tratamiento. |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0939630B1 (es) |
| JP (1) | JP2001500520A (es) |
| KR (1) | KR20000036184A (es) |
| CN (1) | CN1230885A (es) |
| AP (1) | AP9901473A0 (es) |
| AR (1) | AR008838A1 (es) |
| AT (1) | ATE270102T1 (es) |
| AU (1) | AU730465B2 (es) |
| BG (1) | BG103252A (es) |
| BR (1) | BR9712030A (es) |
| CA (1) | CA2266681A1 (es) |
| DE (1) | DE69729735T2 (es) |
| DZ (1) | DZ2311A1 (es) |
| EA (1) | EA199900306A1 (es) |
| ES (1) | ES2223075T3 (es) |
| GB (1) | GB9619492D0 (es) |
| HU (1) | HUP9904638A3 (es) |
| ID (2) | ID23175A (es) |
| IL (1) | IL128786A0 (es) |
| MA (1) | MA24321A1 (es) |
| NO (1) | NO991292D0 (es) |
| NZ (1) | NZ334271A (es) |
| OA (1) | OA10998A (es) |
| PE (1) | PE109898A1 (es) |
| PL (1) | PL332313A1 (es) |
| SK (1) | SK35199A3 (es) |
| TR (1) | TR199900527T2 (es) |
| UY (1) | UY24717A1 (es) |
| WO (1) | WO1998011890A1 (es) |
| ZA (1) | ZA978359B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119214B2 (en) * | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| EP2307004A1 (en) * | 2008-06-05 | 2011-04-13 | Minster Research Limited | Novel treatments |
| EP2296646A2 (en) * | 2008-06-05 | 2011-03-23 | Minster Research Limited | Novel treatments |
| WO2011067607A1 (en) * | 2009-12-03 | 2011-06-09 | Minster Research Ltd | Treatment of infectious diseases |
| EP2464645B1 (en) | 2009-07-27 | 2017-07-05 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| RU2012124837A (ru) * | 2009-12-03 | 2014-01-10 | Проксимэджен ЛТД | Лечение аллодинии и гипералгезии |
| EA026385B9 (ru) | 2010-07-02 | 2017-08-31 | Джилид Сайэнс, Инк. | Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов |
| ES2785475T3 (es) | 2011-05-10 | 2020-10-07 | Gilead Sciences Inc | Compuestos heterocíclicos fusionados como moduladores de canales iónicos |
| NO3175985T3 (es) | 2011-07-01 | 2018-04-28 | ||
| UY34171A (es) | 2011-07-01 | 2013-01-31 | Gilead Sciences Inc | Compuestos heterocíclicos fusionados como moduladores del canal iónico |
| CN106397317B (zh) * | 2016-09-26 | 2019-03-22 | 天津师范大学 | 1,2,3,4-四氢喹啉化合物及其合成方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
| US5510375A (en) * | 1993-11-19 | 1996-04-23 | Warner-Lambert Company | Coumarin derivatives as protease inhibitors and antiviral agents |
| SG67930A1 (en) * | 1994-06-10 | 1999-10-19 | Smithkline Beecham Plc | Benzopyrans and their use as therapeutic agents |
| GB9411635D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
-
1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
-
1997
- 1997-09-15 EP EP97909300A patent/EP0939630B1/en not_active Expired - Lifetime
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Application Discontinuation
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/xx unknown
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Application Discontinuation
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
-
1999
- 1999-03-15 BG BG103252A patent/BG103252A/xx unknown
- 1999-03-17 NO NO991292A patent/NO991292D0/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998011890A1 (en) | 1998-03-26 |
| NO991292L (no) | 1999-03-17 |
| NO991292D0 (no) | 1999-03-17 |
| JP2001500520A (ja) | 2001-01-16 |
| UY24717A1 (es) | 2001-08-27 |
| KR20000036184A (ko) | 2000-06-26 |
| CA2266681A1 (en) | 1998-03-26 |
| ES2223075T3 (es) | 2005-02-16 |
| EP0939630A1 (en) | 1999-09-08 |
| HUP9904638A2 (hu) | 2001-05-28 |
| EP0939630B1 (en) | 2004-06-30 |
| DZ2311A1 (fr) | 2002-12-28 |
| HUP9904638A3 (en) | 2001-08-28 |
| IL128786A0 (en) | 2000-01-31 |
| OA10998A (en) | 2003-03-04 |
| AU730465B2 (en) | 2001-03-08 |
| BG103252A (en) | 1999-09-30 |
| GB9619492D0 (en) | 1996-10-30 |
| MA24321A1 (fr) | 1998-04-01 |
| PE109898A1 (es) | 1999-03-21 |
| BR9712030A (pt) | 1999-08-24 |
| ZA978359B (en) | 1999-03-17 |
| ID23175A (id) | 2000-03-23 |
| ID19542A (id) | 1998-07-23 |
| SK35199A3 (en) | 2000-07-11 |
| CN1230885A (zh) | 1999-10-06 |
| AP9901473A0 (en) | 1999-03-31 |
| EA199900306A1 (ru) | 1999-08-26 |
| ATE270102T1 (de) | 2004-07-15 |
| PL332313A1 (en) | 1999-08-30 |
| TR199900527T2 (xx) | 1999-06-21 |
| DE69729735T2 (de) | 2005-07-14 |
| DE69729735D1 (de) | 2004-08-05 |
| NZ334271A (en) | 2001-03-30 |
| AU4704797A (en) | 1998-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR008838A1 (es) | Nuevo tratamiento. | |
| DE60216139D1 (de) | Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen | |
| ATE214903T1 (de) | Verwendung von perfluorkohlenwasserstoffen zur herstellung von potenzierungsmitteln für die ultraschallvermittelte hyperthermiebehandlung von biologischen geweben | |
| WO2004060146A3 (en) | Method of treatment for central nervous system injury | |
| IL191068A0 (en) | Apparatus for treating neurological disorders by means of chronic adaptive brain stimulation as a function of local biopotentials | |
| ATE381935T1 (de) | Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen | |
| DE60324449D1 (de) | Inhibitoren der phosphodiesterase der zyklischen n, und deren verwendung in therapie | |
| ES2082887T3 (es) | Flupirtina en combinacion con antiparkinsonianos para combatir espasmos musculares. | |
| CY1107054T1 (el) | Ενωσεις διτοσυλικου αλατος κιναζολινης | |
| DE69827513D1 (de) | Anordnung zur behandlung von neurodegenerativen störungen mittels infusion von nervenwachstumsfaktoren in das gehirn | |
| AU2001273574A1 (en) | Substituted 5-alkynyl pyrimidines having neurotrophic activity | |
| MY176938A (en) | 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d] pyrimidin-2-one compounds and prodrugs thereof | |
| WO2007061750A3 (en) | Adipose tissue derived stromal cells for the treatment of neurological disorders | |
| EP0970720A3 (en) | Treatment of pain and the nervous system | |
| SG47918A1 (en) | Chloropyrimidine intermediates | |
| FI964341A (fi) | Prosessi ja laitteisto, joilla vähennetään kehon tietyissä kohdissa olevaa rasvakudosta yhdistetyllä lämpökäsittelyllä ja lihastoiminnalla | |
| EP0533585B1 (en) | Apparatus for regulating and improving the status of development and survival of living organisms | |
| GT200000203A (es) | Compuestos, composiciones y metodos para estimular el crecimiento y elongacion de neuronas. | |
| WO2002066469A3 (en) | Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands | |
| WO2005081619A3 (en) | Compounds and methods for increasing neurogenesis | |
| DE69923998D1 (de) | Verwendung eines neurologischen wirkstoffes zur herstellung eines medikamentes zur behandlung von erkrankungen des zentralen nervensystems | |
| GB9425730D0 (en) | Compounds | |
| WO2000061231A3 (en) | Medical use | |
| WO1999056666A8 (en) | The treatment of sexual dysfunction in certain patient groups | |
| ECSP972256A (es) | Nuevo tratamiento y/o profilaxis de enfermedades degenerativas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |